Cargando…

Advanced [(18)F]FDG and [(11)C]flumazenil PET analysis for individual outcome prediction after temporal lobe epilepsy surgery for hippocampal sclerosis

PURPOSE: We have previously shown that an imaging marker, increased periventricular [(11)C]flumazenil ([(11)C]FMZ) binding, is associated with failure to become seizure free (SF) after surgery for temporal lobe epilepsy (TLE) with hippocampal sclerosis (HS). Here, we investigated whether increased p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yankam Njiwa, J., Gray, K.R., Costes, N., Mauguiere, F., Ryvlin, P., Hammers, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299974/
https://www.ncbi.nlm.nih.gov/pubmed/25610774
http://dx.doi.org/10.1016/j.nicl.2014.11.013
_version_ 1782353458422087680
author Yankam Njiwa, J.
Gray, K.R.
Costes, N.
Mauguiere, F.
Ryvlin, P.
Hammers, A.
author_facet Yankam Njiwa, J.
Gray, K.R.
Costes, N.
Mauguiere, F.
Ryvlin, P.
Hammers, A.
author_sort Yankam Njiwa, J.
collection PubMed
description PURPOSE: We have previously shown that an imaging marker, increased periventricular [(11)C]flumazenil ([(11)C]FMZ) binding, is associated with failure to become seizure free (SF) after surgery for temporal lobe epilepsy (TLE) with hippocampal sclerosis (HS). Here, we investigated whether increased preoperative periventricular white matter (WM) signal can be detected on clinical [(18)F]FDG-PET images. We then explored the potential of periventricular FDG WM increases, as well as whole-brain [(11)C]FMZ and [(18)F]FDG images analysed with random forest classifiers, for predicting surgery outcome. METHODS: Sixteen patients with MRI-defined HS had preoperative [(18)F]FDG and [(11)C]FMZ-PET. Fifty controls had [(18)F]FDG-PET (30), [(11)C]FMZ-PET (41), or both (21). Periventricular WM signal was analysed using Statistical Parametric Mapping (SPM8), and whole-brain image classification was performed using random forests implemented in R (http://www.r-project.org). Surgery outcome was predicted at the group and individual levels. RESULTS: At the group level, non-seizure free (NSF) versus SF patients had periventricular increases with both tracers. Against controls, NSF patients showed more prominent periventricular [(11)C]FMZ and [(18)F]FDG signal increases than SF patients. All differences were more marked for [(11)C]FMZ. For individuals, periventricular WM signal increases were seen at optimized thresholds in 5/8 NSF patients for both tracers. For SF patients, 1/8 showed periventricular signal increases for [(11)C]FMZ, and 4/8 for [(18)F]FDG. Hence, [(18)F]FDG had relatively poor sensitivity and specificity. Random forest classification accurately identified 7/8 SF and 7/8 NSF patients using [(11)C]FMZ images, but only 4/8 SF and 6/8 NSF patients with [(18)F]FDG. CONCLUSION: This study extends the association between periventricular WM increases and NSF outcome to clinical [(18)F]FDG-PET, but only at the group level. Whole-brain random forest classification increases [(11)C]FMZ-PET's performance for predicting surgery outcome.
format Online
Article
Text
id pubmed-4299974
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-42999742015-01-21 Advanced [(18)F]FDG and [(11)C]flumazenil PET analysis for individual outcome prediction after temporal lobe epilepsy surgery for hippocampal sclerosis Yankam Njiwa, J. Gray, K.R. Costes, N. Mauguiere, F. Ryvlin, P. Hammers, A. Neuroimage Clin Regular Article PURPOSE: We have previously shown that an imaging marker, increased periventricular [(11)C]flumazenil ([(11)C]FMZ) binding, is associated with failure to become seizure free (SF) after surgery for temporal lobe epilepsy (TLE) with hippocampal sclerosis (HS). Here, we investigated whether increased preoperative periventricular white matter (WM) signal can be detected on clinical [(18)F]FDG-PET images. We then explored the potential of periventricular FDG WM increases, as well as whole-brain [(11)C]FMZ and [(18)F]FDG images analysed with random forest classifiers, for predicting surgery outcome. METHODS: Sixteen patients with MRI-defined HS had preoperative [(18)F]FDG and [(11)C]FMZ-PET. Fifty controls had [(18)F]FDG-PET (30), [(11)C]FMZ-PET (41), or both (21). Periventricular WM signal was analysed using Statistical Parametric Mapping (SPM8), and whole-brain image classification was performed using random forests implemented in R (http://www.r-project.org). Surgery outcome was predicted at the group and individual levels. RESULTS: At the group level, non-seizure free (NSF) versus SF patients had periventricular increases with both tracers. Against controls, NSF patients showed more prominent periventricular [(11)C]FMZ and [(18)F]FDG signal increases than SF patients. All differences were more marked for [(11)C]FMZ. For individuals, periventricular WM signal increases were seen at optimized thresholds in 5/8 NSF patients for both tracers. For SF patients, 1/8 showed periventricular signal increases for [(11)C]FMZ, and 4/8 for [(18)F]FDG. Hence, [(18)F]FDG had relatively poor sensitivity and specificity. Random forest classification accurately identified 7/8 SF and 7/8 NSF patients using [(11)C]FMZ images, but only 4/8 SF and 6/8 NSF patients with [(18)F]FDG. CONCLUSION: This study extends the association between periventricular WM increases and NSF outcome to clinical [(18)F]FDG-PET, but only at the group level. Whole-brain random forest classification increases [(11)C]FMZ-PET's performance for predicting surgery outcome. Elsevier 2014-11-27 /pmc/articles/PMC4299974/ /pubmed/25610774 http://dx.doi.org/10.1016/j.nicl.2014.11.013 Text en © 2014 The Authors. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Regular Article
Yankam Njiwa, J.
Gray, K.R.
Costes, N.
Mauguiere, F.
Ryvlin, P.
Hammers, A.
Advanced [(18)F]FDG and [(11)C]flumazenil PET analysis for individual outcome prediction after temporal lobe epilepsy surgery for hippocampal sclerosis
title Advanced [(18)F]FDG and [(11)C]flumazenil PET analysis for individual outcome prediction after temporal lobe epilepsy surgery for hippocampal sclerosis
title_full Advanced [(18)F]FDG and [(11)C]flumazenil PET analysis for individual outcome prediction after temporal lobe epilepsy surgery for hippocampal sclerosis
title_fullStr Advanced [(18)F]FDG and [(11)C]flumazenil PET analysis for individual outcome prediction after temporal lobe epilepsy surgery for hippocampal sclerosis
title_full_unstemmed Advanced [(18)F]FDG and [(11)C]flumazenil PET analysis for individual outcome prediction after temporal lobe epilepsy surgery for hippocampal sclerosis
title_short Advanced [(18)F]FDG and [(11)C]flumazenil PET analysis for individual outcome prediction after temporal lobe epilepsy surgery for hippocampal sclerosis
title_sort advanced [(18)f]fdg and [(11)c]flumazenil pet analysis for individual outcome prediction after temporal lobe epilepsy surgery for hippocampal sclerosis
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299974/
https://www.ncbi.nlm.nih.gov/pubmed/25610774
http://dx.doi.org/10.1016/j.nicl.2014.11.013
work_keys_str_mv AT yankamnjiwaj advanced18ffdgand11cflumazenilpetanalysisforindividualoutcomepredictionaftertemporallobeepilepsysurgeryforhippocampalsclerosis
AT graykr advanced18ffdgand11cflumazenilpetanalysisforindividualoutcomepredictionaftertemporallobeepilepsysurgeryforhippocampalsclerosis
AT costesn advanced18ffdgand11cflumazenilpetanalysisforindividualoutcomepredictionaftertemporallobeepilepsysurgeryforhippocampalsclerosis
AT mauguieref advanced18ffdgand11cflumazenilpetanalysisforindividualoutcomepredictionaftertemporallobeepilepsysurgeryforhippocampalsclerosis
AT ryvlinp advanced18ffdgand11cflumazenilpetanalysisforindividualoutcomepredictionaftertemporallobeepilepsysurgeryforhippocampalsclerosis
AT hammersa advanced18ffdgand11cflumazenilpetanalysisforindividualoutcomepredictionaftertemporallobeepilepsysurgeryforhippocampalsclerosis